HighTower Advisors LLC Has $945,000 Stock Holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

HighTower Advisors LLC decreased its stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 3.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 13,392 shares of the company’s stock after selling 512 shares during the period. HighTower Advisors LLC owned 0.13% of iShares U.S. Pharmaceuticals ETF worth $945,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of IHE. Allworth Financial LP grew its stake in shares of iShares U.S. Pharmaceuticals ETF by 9.4% in the third quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock valued at $131,000 after acquiring an additional 159 shares in the last quarter. Assetmark Inc. increased its holdings in shares of iShares U.S. Pharmaceuticals ETF by 100.0% during the third quarter. Assetmark Inc. now owns 432 shares of the company’s stock worth $31,000 after purchasing an additional 216 shares during the period. US Bancorp DE raised its position in shares of iShares U.S. Pharmaceuticals ETF by 137.0% in the third quarter. US Bancorp DE now owns 384 shares of the company’s stock valued at $27,000 after buying an additional 222 shares in the last quarter. Mercer Global Advisors Inc. ADV raised its position in shares of iShares U.S. Pharmaceuticals ETF by 7.4% in the second quarter. Mercer Global Advisors Inc. ADV now owns 3,837 shares of the company’s stock valued at $254,000 after buying an additional 266 shares in the last quarter. Finally, Cultivar Capital Inc. bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the second quarter valued at approximately $25,000.

iShares U.S. Pharmaceuticals ETF Price Performance

iShares U.S. Pharmaceuticals ETF stock opened at $66.83 on Wednesday. The stock’s fifty day moving average price is $69.24 and its two-hundred day moving average price is $69.07. The firm has a market cap of $674.98 million, a PE ratio of 6.49 and a beta of 0.58. iShares U.S. Pharmaceuticals ETF has a one year low of $59.82 and a one year high of $72.94.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.